Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125

Published:2018-06 Issue:6 Volume:47 Page:227-230
ISSN:2468-7847
Container-title:Journal of Gynecology Obstetrics and Human Reproduction
language:en
Short-container-title:Journal of Gynecology Obstetrics and Human Reproduction

Author:

Zheng Xin,Chen Shulin,Li Linfang,Liu Xiaohua,Liu Xiaomin,Dai Shuqin,Zhang Peng,Lu Huaiwu,Lin Zhongqiu,Yu Yuefei,Li Guorong

Funder

2016 Guangzhou major project of industry-university-research cooperative innovation

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference21 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Rebelo;Int J Cancer,2015

2. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study;De Angelis;Lancet Oncol,2014

3. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival;Cliby;Gynecol Oncol,2015

4. Evaluation of HE4 as an extra biomarker to CA125 to improve detection of ovarian carcinoma: is it time for step forward?;Azzam;Arch Gynecol Obstet,2013

5. Diagnostic performance of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases;Park;Clin Biochem,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool;Frontiers in Molecular Biosciences;2024-04-16

2. Electrochemical immunosensing of tumor markers;Clinica Chimica Acta;2024-04

3. Biomarkers in Ovarian Cancer: Towards Personalized Medicine;Proteomes;2024-03-18

4. High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive;Biomedicines;2024-01-19

5. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer;Diagnostics;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3